Treatment for Extrapyramidal Symptoms from Antipsychotics
For acute dystonia, administer benztropine 1-2 mg IM/IV immediately as first-line treatment. 1
Immediate Management by EPS Type
Acute Dystonia (sudden muscle spasms, typically within first few days)
- Administer benztropine 1-2 mg IM/IV immediately 1
- Alternative option: benzodiazepines can be used if anticholinergics are contraindicated 2
- Continue anticholinergic medications even after antipsychotic discontinuation to prevent delayed symptom emergence 1
- Critical pitfall: Young males are at highest risk for acute dystonia, requiring immediate recognition and treatment 1
Drug-Induced Parkinsonism (bradykinesia, tremors, rigidity)
- First strategy: reduce the antipsychotic dose 1
- Second strategy: switch to atypical antipsychotic with lower EPS risk (olanzapine, quetiapine, or clozapine) 1
- If dose reduction/switching fails: add anticholinergic agent or amantadine 2
- Anticholinergics should NOT be used routinely for prevention, only for treatment of significant symptoms after other strategies fail 1
Akathisia (subjective restlessness, motor agitation)
- First-line: lipophilic beta-blockers, particularly propranolol or metoprolol 2
- If beta-blockers ineffective or contraindicated: try anticholinergics or benzodiazepines 2
- Common pitfall: Akathisia is frequently misinterpreted as anxiety or psychotic agitation, leading to inappropriate dose increases that worsen the problem 1
- This symptom carries high risk of medication non-compliance 1
Tardive Dyskinesia (involuntary movements from long-term use)
- Use same strategies as dystonia: reduce dose or switch medication 1
- Maintain current antipsychotic only if patient is in complete remission and medication change would precipitate relapse 1
- Important note: Clozapine has therapeutic value in established tardive dyskinesia cases 3
Severe EPS Management
- In cases of severe extrapyramidal symptoms, anticholinergic medication should be administered immediately 4
- Critical warning: Anticholinergic medications like benztropine can cause delirium, drowsiness, and paradoxical agitation 1
Prevention Strategy (Not Routine Prophylaxis)
- Use lowest effective antipsychotic dose: maximum 4-6 mg haloperidol equivalent in first-episode psychosis 1
- For risperidone specifically: keep doses at 2-4 mg/day in adults; EPS risk increases significantly above 2 mg/day 1
- Regular monitoring for early EPS signs is the preferred prevention strategy, NOT prophylactic anticholinergics 1
- Prophylactic anticholinergics should be reserved only for high-risk patients (young males starting high-potency typical antipsychotics) and discontinued after 2 weeks 1, 5
Medication Selection to Minimize Future EPS
- Atypical antipsychotics with lowest EPS risk: olanzapine, quetiapine, clozapine 1
- High-potency typical antipsychotics (haloperidol) carry highest risk 1
- Risperidone has dose-dependent EPS risk higher than other atypicals 1
Key Clinical Pitfalls
- Never use epinephrine or dopamine for hypotension in antipsychotic overdose with EPS, as beta stimulation worsens hypotension with quetiapine-induced alpha blockade 4
- Long-term antiparkinsonian treatment is not therapeutically beneficial; gradual withdrawal does not produce EPS recurrence 5
- Patients with EPS have significantly more negative symptoms and poorer functional outcomes 6, 7
- EPS prevalence remains 13.2% for parkinsonism and 8.3% for tardive dyskinesia even in stabilized community patients 7